Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer

por Scheidemann, Erin R., Shajahan-Haq, Ayesha N.
Publicado 2021

Application of Metabolomics in Drug Resistant Breast Cancer Research

por Shajahan-Haq, Ayesha N., Cheema, Mehar S., Clarke, Robert
Publicado 2015

MYC-Driven Pathways in Breast Cancer Subtypes

por Fallah, Yassi, Brundage, Janetta, Allegakoen, Paul, Shajahan-Haq, Ayesha N.
Publicado 2017

Modeling breast cancer proliferation, drug synergies, and alternating therapies

por He, Wei, Demas, Diane M., Shajahan-Haq, Ayesha N., Baumann, William T.
Publicado 2023

Dynamic Modeling of the Interaction Between Autophagy and Apoptosis in Mammalian Cells

por Tavassoly, I, Parmar, J, Shajahan-Haq, AN, Clarke, R, Baumann, WT, Tyson, JJ
Publicado 2015

Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors

por Fallah, Yassi, Demas, Diane M., Jin, Lu, He, Wei, Shajahan-Haq, Ayesha N.
Publicado 2021

Mathematical modelling of breast cancer cells in response to endocrine therapy and Cdk4/6 inhibition

por He, Wei, Demas, Diane M., Conde, Isabel P., Shajahan-Haq, Ayesha N., Baumann, William T.
Publicado 2020

Inhibition of DNA Repair Pathways and Induction of ROS Are Potential Mechanisms of Action of the Small Molecule Inhibitor BOLD-100 in Breast Cancer

por Bakewell, Suzanne, Conde, Isabel, Fallah, Yassi, McCoy, Mathew, Jin, Lu, Shajahan-Haq, Ayesha N.
Publicado 2020

Glutamine metabolism and the unfolded protein response in MYC-driven breast cancer

por Shajahan-Haq, Ayesha, Cook, Katherine, Schwartz-Roberts, Jessica, Eltayeb, Ahreej, Demas, Diane, Warri, Anni, Hilakivi-Clarke, Leena, Clarke, Robert
Publicado 2014

Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer

por Demas, Diane M., Demo, Susan, Fallah, Yassi, Clarke, Robert, Nephew, Kenneth P., Althouse, Sandra, Sandusky, George, He, Wei, Shajahan-Haq, Ayesha N.
Publicado 2019

ChIP-BIT: Bayesian inference of target genes using a novel joint probabilistic model of ChIP-seq profiles

por Chen, Xi, Jung, Jin-Gyoung, Shajahan-Haq, Ayesha N., Clarke, Robert, Shih, Ie-Ming, Wang, Yue, Magnani, Luca, Wang, Tian-Li, Xuan, Jianhua
Publicado 2016

Caveolin-1 regulates cancer cell metabolism via scavenging Nrf2 and suppressing MnSOD-driven glycolysis

por Hart, Peter C., Ratti, Bianca A., Mao, Mao, Ansenberger-Fricano, Kristine, Shajahan-Haq, Ayesha N., Tyner, Angela L., Minshall, Richard D., Bonini, Marcelo G.
Publicado 2015

PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast c...

por Lynce, Filipa, Saleh, Mervat, Shajahan-Haq, Ayesha, Gallagher, Christopher, Dilawari, Asma, Hahn, Olwen, Abu-Khalaf, Maysa, Cai, Ling, Pohlmann, Paula, Mohebtash, Mahsa, Kamugisha, Lois, Isaacs, Claudine
Publicado 2018

EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer

por Shajahan-Haq, Ayesha N., Boca, Simina M., Jin, Lu, Bhuvaneshwar, Krithika, Gusev, Yuriy, Cheema, Amrita K., Demas, Diane D., Raghavan, Kristopher S., Michalek, Ryan, Madhavan, Subha, Clarke, Robert
Publicado 2017

MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer

por Shajahan-Haq, Ayesha N, Cook, Katherine L, Schwartz-Roberts, Jessica L, Eltayeb, Ahreej E, Demas, Diane M, Warri, Anni M, Facey, Caroline O B, Hilakivi-Clarke, Leena A, Clarke, Robert
Publicado 2014

Caveolin-1 controls mitochondrial damage and ROS production by regulating fission - fusion dynamics and mitophagy

por Jiang, Ying, Krantz, Sarah, Qin, Xiang, Li, Shun, Gunasekara, Hirushi, Kim, Young-Mee, Zimnicka, Adriana, Bae, Misuk, Ma, Ke, Toth, Peter T., Hu, Ying, Shajahan-Haq, Ayesha N., Patel, Hemal H., Gentile, Saverio, Bonini, Marcelo G., Rehman, Jalees, Liu, Yiyao, Minshall, Richard D.
Publicado 2022

Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study

por Lynce, F., Barac, A., Geng, X., Dang, C., Yu, A. F., Smith, K. L., Gallagher, C., Pohlmann, P. R., Nunes, R., Herbolsheimer, P., Warren, R., Srichai, M. B., Hofmeyer, M., Cunningham, A., Timothee, P., Asch, F. M., Shajahan-Haq, A., Tan, M. T., Isaacs, C., Swain, S. M.
Publicado 2019